MODERNA, INC.

MRNA
Real-time Estimate Quote. Real-time Estimate  - 12/01 07:12:50 am
343.915USD -2.42%

Turn to zoom
Prev.352.4300
Open351.5800
High357.6399
Low337.2900
Volume24 691 302
Latest news
1h ago
2h ago
3h ago
3h ago
Chart MODERNA, INC.
Technical analysis trends
Short TermMid-TermLong Term
TrendBullishNeutralBullish
Resistance369484449
Spread/Res.-4,4%-27%-22%
Spread/Supp.25%78%61%
Support283198219
Financials
Sales 2021 17 449 M - -
Net income 2021 11 169 M - -
Net cash 2021 12 344 M - -
P/E ratio 2021 13,4x
Yield 2021 -
Capitalization 143 B 143 B -
EV / Sales 2021 7,48x
EV / Sales 2022 5,84x
Nbr of Employees 1 300
Free-Float 90,5%
Company
Moderna, Inc. is a biotechnology company specialized in research and development of therapeutics and vaccines for infectious, autoimmune and cardiovascular diseases. Turnover per type of income can be broken down as follows:
- Collaboration revenue (79.8%);
- Grant revenue (20.2%).
At the end...

>> Read more
Sector :
Other Biotechnology & Medical Research
Calendar :
2022-03-09 Earnings Release
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 18
Last Close Price 352,43 $
Average target price 272,53 $
Spread / Average Target -22,7%